Detection of isoflavones in mouse tibia after feeding daidzein

Journal of Medicinal Food

Volumn 9, Issue 3, 2006, Pages 436-439

  Fonseca, Debbie ^a   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone extraction; Daidzein; Equol; Ovariectomized mice; Tibia

Indexed keywords

DAIDZEIN; EQUOL; ISOFLAVONE; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BONE; BONE LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FLUOROIMMUNOASSAY; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; TIBIA; ANIMAL; C57BL MOUSE; CHEMISTRY; DIET; FEMALE;

ANIMALS; BONE AND BONES; DIET; FEMALE; ISOFLAVONES; MICE; MICE, INBRED C57BL; OVARIECTOMY; TIBIA;

EID: 33750632321     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.436     Document Type: Article

References (27)

1. Fonseca D, Ward WE: Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 2004;35:489-497.
2. Breitman PL, Fonseca D, Ward WE: Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 2003;33:597-605.
3. Breitman PL, Fonseca D, Ward WE: Combination of soy protein and high dietary calcium on bone biomechanics and bone mineral density in ovariectomized rats. Menopause 2005;12:428-435.
4. Arjmandi BH, Alekel L, Hollis BW, et al.: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-167.
5. Arjmandi BH, Birnbaum R, Goyal NV, et al.: Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998;68(Suppl):1364S-1368S.
6. Arjmandi BH, Getlinger MJ, Goyal NV, et al.: Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998;68(Suppl):1358S-1363S.
7. Fanti P, Monier-Faugere MC, Geng Z, et al.: The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 1998;8:274-281.
8. Draper CR, Dick IM, Prince RL: The effect of estrogen deficiency on calcium balance in mature rats. Calcif Tissue Int 1999;64:325-328.
9. Mori M, Sagara M, Ikeda K, Miki T, Yamori Y: Soy isoflavones improve bone metabolism in postmenopausal Japanese women. Clin Exp Pharmacol Physiol 2004;31(Suppl):S44-S46.
10. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA: The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2004;79:326-333.
11. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-852.
12. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr: Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(Suppl):1375S-1379S.
13. Harkness LS, Fiedler K, Sehgal AR, Oravec D, Lerner E: Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt) 2004;13:1000-1007.
14. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T: Soymilk or progesterone for prevention of bone loss - a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004;43:246-257.
15. Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584.
16. Chang H, Jin TY, Jin WF, Gu SZ, Zhou YF: Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed Environ Sci 2003;16:83-89.
17. De Wilde A, Lieberherr M, Colin C, Pointillart A: A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. J Cell Physiol 2004;200:253-262.
18. Jia TL, Wang HZ, Xie LP, Wang XY, Zhang RQ: Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 2003;65:709-715.
19. Kanno S, Hirano S, Kayama F: Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 2004;196:137-145.
20. Garcia Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE, Blair HCL: Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J Biol Chem 2005;280:13720-13727.
21. Canadian Council on Animal Care: Guide to the Care and Use of Experimental Animals, Institute of Laboratory Animal Resources Commission on Life Sciences, Ottawa, 1984.
22. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951.
23. Dalais FS, Ebeling PR, Kotsopoulos D, McGrath BP, Teede HJ: The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) 2003;58:704-709.
24. Cai DJ, Zhao Y, Glasier J, et al.: Comparative effect of soy protein, soy isoflavones and 17beta-estradiol on bone metabolism in adult ovariectomized rats. J Bone Mineral Res 2005;20:828-839.
25. Wang C, Zhang Y: Effects of protein source and soy isoflavone on bone mineral content and bone density of ovariectomized rats [abstract]. FASEB J 2002;16:A623.
26. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V: The effect of soy protein isolate on bone metabolism. Menopause 2004;11:290-298.
27. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al.: Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized, controlled trial. Obstet Gynecol Surv 2005;60:41-43.